Professional Documents
Culture Documents
OCT. 2015
W
W
W
.
C
A
P
I
T
A
L
S
T
A
R
S
.
C
O
M
MARKET SNAPSHOT
SYMBOL
OPEN
HIGH
LOW
CLOSE
CHANGE
NIFTY
8196
8196
8105
8129
-0.59%
SENSEX
27116
27120
26762
26845
-0.70%
Nifty levels:
Nifty spot close @8129
Nifty future close @8157
SYMBOL
NIFTY SPOT
NIFTY
FUTURE
S1
8090
8123
S2
8052
8089
PIVOT
8143
8161
R1
8181
8195
R2
8324
8233
Consolidation from upper level we have seen today, though buying opportunity on every
dip. We may see 8225 level as a next resistance level, more buying will be seen from this
level.
SYMBOL
BANKNIFTY
SPOT
BANKNIFTY
FUTURE
S1
S2
PIVOT
R1
R2
17376
17278
17499
17597
17720
17440
17339
17571
17672
17803
View on Banknifty
Selling opportunity below 17700, we may see 17400/17350 level, above 177700 we may
see 17850 as a strong resistance level.
Market Commentary
MARKET COMMENTERY
Private sector banks, auto and pharma sector stocks and index heavyweights ITC and
Reliance Industries led losses for key benchmark indices which languished in red almost
throughout the trading session. The barometer index, the S&P BSE Sensex, dropped
182.35 points or 0.68% at 26,853.32, as per the provisional closing data. The 50-unit CNX
Nifty declined 48.05 points or 0.59% at 8,129.35, as per the provisional closing data. The
Sensex provisionally settled below the psychological 27,000 mark. Modest gains had
helped the Sensex reclaim the psychological 27,000 mark yesterday, 7 October 2015.
STOCK BUZZ
Tata Power Company declined 0.43%. The company announced that it has
launched a LED tube light program for its residential consumers in Mumbai to
encourage them to adopt energy efficient lights, thereby saving power. The
company announced during market hours today, 8 October 2015. Under this
programmer, each residential consumer is eligible to procure 5 LED tube lights
fittings at a price of Rs 525 each, against a market price of Rs 1325 each.
Cipla slipped 0.32%. The company announced that its South African subsidiary
Cipla Medpro (Pty) Ltd. has entered into an exclusive agreement with the
world's largest vaccine manufacturer, Serum Institute of India (SII) in South
Africa to supply of vaccines in South Africa. SII manufactures a variety of
vaccine classes including vaccines for Polio, Diphtheria, Tetanus, BCG
(Tuberculosis), Hepatitis B, Measles, Mumps and Rubella. South Africa will be
participating in the majority of these portfolios. Cipla Medpro has exclusivity
and first right of refusal of the SII pipeline within South Africa.
HOT PURSUIT
Mahindra & Mahindra (M&M) declined 0.98%. The company announced during
market hours today, 8 October 2015, that global credit rating agency Moody's
Investors Service has assigned Baa3 foreign currency and local currency issuer rating
with stable outlook to the company. The rating reflects M&M's diversified business
profile, leading market position in India, long track record of successful operations,
strong corporate governance practices, financial flexibility and conservative
financial policies.
Rajesh Exports rose 1.85% after the company said it has secured an export order
worth Rs 1360 crore of designer range of gold and diamond studded jewellery and
medallions from UAE. The company announced the new order during market hours
today, 8 October 2015. Rajesh Exports said that the execution of its latest export
order will significantly add to the bottom line of the company.
OPTION STRATEGY
In todays session we have seen callbuying in 8100 and 8200 strike price, we may see 8200 as a
strong resistance level in coming days.
RELIANCE900 and 920 calls and putswere so active, we may see buyingabove900 level.
INFOSIS 1160putswere so active today, we may see more selling below 1160.
STOCKS TO WATCH
MARUTI:
SELL MARUTI AS REMAIN BELOW 4400 WE MAY SEE 4200/4100 IN COMING DAYS.
ONGC:
Buy ONGC above 250 level we may see 270/280, below 250 major support will be
242.
GAIL:
Sell GAIL as remain below 310 we may see 300/290 level in coming days.
DISCLAIMER
The information and views in this report, our website & all the service we provide are believed to be
reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the
right to choose the product/s that suits them the most.
Use of this report in no way constitutes a client/advisor relationship, all information we communicate to
you (the subscriber) either through our Web site or other forms of communications, are purely for
informational purposes only.
We recommend seeking individual investment advice before making any investment, for you are
assuming sole liability for your investments. Capital Stars will in no way have discretionary authority
over your trading or investment accounts.
All rights reserved.